Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ZOLKAR 50 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ZOLKAR 50 MG COMPRIMIDOS

Approved

STANDARD

ZOLKAR 50 MG COMPRIMIDOS

Accord Healthcare S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 26, 2021
Approval ID: d3e566ef27a22e31
Company: Accord Healthcare S.L.U.
Type: Standard

Approval Details

Approval Id: d3e566ef27a22e31
Drug Cima Aemps Name: ZOLKAR 50 MG COMPRIMIDOS
Register Number: 85555
Holder Company Name: Accord Healthcare S.L.U.
Marketing Company Name: Accord Healthcare S.L.U.
Holder Company Detail Path: /organization/accord-healthcare-sl
Marketing Company Detail Path: /organization/accord-healthcare-sl
Authorization Date: 2021-10-26
Dosage Form: COMPRIMIDO
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Accord Healthcare S.L.U.
Company Detail Path: /organization/accord-healthcare-sl

Company Information

Pharmaceutical Company Name: ACCORD HEALTHCARE SL
Country Name: Spain
City Name: barcelona,barcelona,country_es
Address: CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N

Active Ingredients

CLOZAPINA

50 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 26, 2021

Approval ID

d3e566ef27a22e31

Type

Standard

Back to CIMA-AEMPS Approvals